TTK Healthcare's Q2 FY25 financials show flat performance with concerns over non-operating income

TTK Healthcare, a smallcap pharmaceutical and drugs company, has recently declared its financial results for the quarter ended September 2024. The company’s stock has been given a ‘Hold’ call by MarketsMOJO.

According to the financial report, TTK Healthcare has shown a flat performance in the quarter, with a score of 0 compared to -2 in the previous quarter. However, there are some positive aspects to the company’s financials. The dividend per share (DPS) has been consistently high at Rs 10.00 annually for the past five years, indicating that the company is distributing higher dividends from its profits.

On the other hand, there are also some concerns regarding TTK Healthcare’s financials. The non-operating income for the quarter is 76.33% of the profit before tax (PBT), which suggests that the company’s income from non-business activities is high. This may not be a sustainable business model in the long run. Additionally, the non-operating income for the quarter is at its highest in the last five quarters, which could be a cause for concern as increased income from non-business activities may not be sustainable.

Overall, TTK Healthcare’s financial performance for the quarter ending September 2024 has been flat, with some positive and negative aspects. Investors are advised to hold their position in the company’s stock, as suggested by MarketsMOJO.